Cosma S.A.
0.39
PLN
0.00
(0.00%)
ISIN
PLVBN0000015
Return %
Stock
S&P 500
1Y
11.43
14.20
3Y
-17.37
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Przemyslaw Lahuta
- Full Time Employees
- 29
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Warsaw Poland
- IPO Date
- Jun 28, 2018
- Website
- cosma.pl
- Similar Companies
- Business
- Cosma S.A. operates as a pharmaceutical and healthcare company specializing in the development, authorization, production, and distribution of medical cannabis, active pharmaceutical raw materials, and phytocannabinoid-based consumer wellness formulations. The company functions across vertically integrated business units encompassing prescription pharmaceuticals, consumer health products, toll extraction services, and wholesale pharmaceutical logistics. Its product and service portfolio includes standardized pharmaceutical-grade medical cannabis flower (Cannabis flos) featuring defined cannabinoid concentrations such as THC 20% and THC 21% chemotypes; prescription cannabinoid extracts, broad-spectrum tinctures, and formulated oils; over-the-counter dietary supplements and herbal health preparations marketed under the Cosma and Full Spectrum brands; cannabinoid-infused animal care and cosmetic products under the Green Paw brand; supercritical carbon dioxide (CO2) extraction and custom contract manufacturing services; and comprehensive Marketing Authorization Holder (MAH) regulatory management alongside temperature-controlled wholesale distribution. Cosma S.A. distributes its products primarily to licensed pharmacies, hospitals, healthcare providers, and retail wellness channels across Poland, supported by an international procurement network spanning Portugal, Spain, and Canada. Founded in 2015 and headquartered in Warsaw, Poland, Cosma S.A. maintains extraction and manufacturing infrastructure in Magnuszew and operates pharmaceutical warehousing facilities in Mszczonow through its distribution subsidiary, Interfarmed Cannabis. The company assumed its current identity and strategic direction following a corporate reorganization and reverse takeover merger with Cosma Cannabis Sp. z o.o. in March 2023, transitioning from its former name Vabun S.A. and trading under the ticker COS on the NewConnect segment of the Warsaw Stock Exchange. In recent operational developments, the company secured formal five-year marketing authorizations from Poland's Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) for its proprietary Cannabis flos formulations, cementing its position as an authorized market holder. To scale its commercial supply chain, Cosma S.A. executed an extended four-year distribution agreement with Portugal-based SOMAI Pharmaceuticals covering co-branded and white-label pharmaceutical oils, entered into a GMP-compliant supply partnership with Portocanna S.A., and established an international distribution alliance with Canadian producer Prime Pot Inc. (EastCann Cannabis). In addition, the company expanded its product registration pipeline by acquiring the regulatory applications and cannabis supply agreements formerly owned by CanPoland S.A. in coordination with Linneo Health S.L., followed by an investment transaction to acquire 100% equity in IMP&C sp. z o.o. to absorb additional authorized pharmaceutical assets.